AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years
English fluency
Provide informed consent
Ability to complete questionnaire(s) by themselves or with assistance
Disqualifiers
Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months
Active delirium
Advanced dementia
Trial design
Design model
Single group
Treatments tested in this trial
AI Assisted Personalized Legacy Program
BehavioralAI Assisted Personalized Legacy Program will be facilitated by a clinician trained in legacy work.
Treatment groups
20 Participants
are divided into 1 treatment groupGroup A: AI Assisted Personalized Legacy ProgramExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Feasibility Number
Study feasibility will be measured by the number of participants who enrolled and finished the study.
Time frame
2 years2
Acceptability
Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns. Positive responses indicate acceptability. Results are reported as individual items.
Time frame
5-10 days post-delivery of the final legacy documentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov